Depressive Symptoms, Pain, Chronic Medical Morbidity, and Interleukin-6 among Primary Care Patients

Pain Medicine (United States)

Volumn 14, Issue 5, 2013, Pages 686-691

  Poleshuck, Ellen L ^a   Talbot, Nancy L ^a   Moynihan, Jan A ^a   Chapman, Benjamin P ^a   Heffner, Kathi L ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Depression; Inflammation; Persistent Pain; Primary Care

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PAIN; PATIENT; PRIMARY MEDICAL CARE; QUALITY OF LIFE;

EID: 84878208811     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12089     Document Type: Article

References (30)

1. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity-A literature review. AMA Arch Intern Med 2003;163(20):2433-2445.
2. Detweiler-Bedell JB, Friedman MA, Leventhal H, Miller IW, Leventhal EA. Integrating co-morbid depression and chronic physical disease management: Identifying and resolving failures in self-regulation. Clin Psychol Rev 2008;28(8):1426-1446.
3. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med 2009;71(2):171-186.
4. Dowlati Y, Herrmann N, Swardfager W, etal. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67(5):446-457.
5. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65(9):732-741.
6. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008;9(1):46-56.
7. Solovieva S, Leino-Arjas P, Saarela J, etal. Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain 2004;109(1-2):8-19.
8. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005;6(7):521-532.
9. Hori TOT, Hosoi M, Aou S. Pain modulatory actions of cytokines and prostaglandin E-2 in the brain. Neuroimmunomodulation 1998;840:269-281.
10. DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 2001;90(1-2):1-6.
11. Watkins LR, Maier SF. The pain of being sick: Implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000;51:29-57.
12. Watkins LR, Maier SF. Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002;82(4):981-1011.
13. Starkweather A, Witek-Janusek L, Mathews HL. Neural-immune interactions: Implications for pain management in patients with low-back pain and sciatica. Biol Res Nurs 2005;6(3):196-206.
14. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361(1-3):184-187.
15. De Jongh RF, Vissers KC, Meert TF, etal. The role of interleukin-6 in nociception and pain. Anesth Analg 2003;96:1096-1103.
16. Barton BE. Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes. Expert Opin Ther Targets 2005;9(4):737-752.
17. Smolen JS, Maini RN. Interleukin-6: A new therapeutic target. Arthritis Res Ther 2006;8(suppl 2):S5.
18. Chapman BP, Khan A, Harper M, etal. Gender, race/ethnicity, personality, and interleukin-6 in urban primary care patients. Brain Behav Immun 2009;23(5):636-642.
19. Eaton WW, Smith C, Ybarra M, Muntaner C, Tien A. Center for Epidemiologic Studies Depression Scale: Review and Revision (CESD and CESD-R). M. M, editor. Princeton, NJ: Lawrence Erlbaum Associates; 2004.
20. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
21. McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
22. Brim OG, Ryff CD, Kessler RC, eds. How Healthy Are We?: A National Study of Well-Being at Midlife. Chicago, IL: The University of Chicago Press; 2004.
23. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005;3(3):223-228.
24. Schulberg HC, Saul M, McClelland M, etal. Assessing depression in primary medical and psychiatric practices. Arch Gen Psychiatry 1985;42(12):1164-1170.
25. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51(6):1173-1182.
26. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40(3):879-891.
27. Lyness JM, Caine ED, King DA, Cox C, Yoediono Z. Psychiatric disorders in older primary care patients. J Gen Intern Med 1999;14(4):249-254.
28. Chapman BP, van Wijngaarden E, Seplaki CL, etal. Openness and conscientiousness predict 34-week patterns of Interleukin-6 in older persons. Brain Behav Immun 2011;25(4):667-673.
29. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996;49(12):1407-1417.
30. Thornton LM, Andersen BL, Schuler TA, Carson WE, 3rd. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: Secondary analysis of a randomized controlled trial. Psychosom Med 2009;71(7):715-724.